Study of Denufosol Inhalation Solution in Patients With Mild Cystic Fibrosis Lung Disease

Clinical trial NCT00357279 · COMPLETED

Trial details

NCT number: NCT00357279
Sponsor: Merck Sharp & Dohme LLC
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Cystic Fibrosis

Start date: 2006-07-01
Primary completion: 2008-09-01
Enrollment: 352

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.